Literature DB >> 3738066

Drug sales data and prevalence of diabetes in France.

A Fontbonne, L Papoz, E Eschwege.   

Abstract

The importance of diabetes in France was estimated on the basis of drug sales data from 1976 to 1982. In 1982, 1.1% of the French population was taking oral hypoglycaemic agents daily, and 0.2%, insulin. These results are compared with the prevalence of diabetes (1.9%) estimated in a 1976 French epidemiologic study carried out on a random sample of practitioners, and other European estimates. The particularly high consumption of oral antidiabetic agents in France is then addressed, in relation to diagnosis and prescription habits.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3738066

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  6 in total

1.  Comparative consumption of antidiabetic drugs in Britain, France and Germany.

Authors:  F Taboulet
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Certification of cause of death in French diabetic patients.

Authors:  B Balkau; L Papoz
Journal:  J Epidemiol Community Health       Date:  1992-02       Impact factor: 3.710

Review 3.  Utilisation of drugs for diabetes mellitus.

Authors:  H I Feldman; B L Strom
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

4.  Hypertension and combinations of cardiovascular risk factors. An epidemiologic case-control study in an adult population in Guadeloupe (FWI).

Authors:  L Foucan; J Bangou-Brédent; D K Ekouévi; J Deloumeaux; J E Roset; P Kangambega
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

5.  Decreased insulin response to glucose in islet cell antibody-negative siblings of type 1 diabetic children.

Authors:  J C Carel; C Boitard; P F Bougnères
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Prevalence of drug-treated diabetes mellitus in Belgium. Results of a study with the collaboration of a network of pharmacies.

Authors:  D Walckiers; J Van der Veken; L Papoz; A Stroobant
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.